Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database
- PMID: 22137080
- PMCID: PMC3233686
- DOI: 10.1016/j.ahj.2011.09.009
Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database
Abstract
Background: Gastrointestinal bleeding (GIB) after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) and coronary artery disease (CAD) is associated with high morbidity and mortality.
Methods: The NIS database from 1998 to 2006 was used to identify 1,216,759 PCIs performed for ACS and CAD. We sought to analyze temporal trends in the incidence and in-hospital outcomes of GIB associated with PCI along with its predictors.
Results: The overall incidence of GIB was 1.04% (95% confidence interval (CI), 1.02%-1.06%). The incidence of GIB decreased over the study period (P for trend <.0001). The overall mortality in the GIB group was 6.0% (95% CI, 5.6%-6.4%). The adjusted OR for in-hospital mortality and GIB was 4.70 (95% CI, 4.23-5.23; P < .0001); this remained high and essentially unchanged over the study period. Independent predictors of GIB included rectum/anal cancer (OR, 4.64; 95% CI, 3.20-6.73; P < .0001), stomach cancer (OR, 2.74; 95% CI, 1.62-4.66; P = .0002), esophageal cancer (OR, 1.99; 95% CI, 1.08-3.69; P = .0288), colon cancer (OR, 1.69; 95% CI, 1.43-2.02; P < .0001), congestive heart failure (OR, 1.43; 95% CI, 1.35-1.52; P < .0001), and acute myocardial infarction (OR, 1.23; 95% CI, 1.13-1.35; P < .0001).
Conclusions: Although the incidence of GIB associated with PCI decreased from 1998 to 2006 in the face of aggressive therapies for ACS and CAD, the risk of GIB-associated death remained high. Underlying GI malignancy is a significant independent predictor of GIB associated with PCI; identifying these patients may reduce the rate of GIB.
Copyright © 2011 Mosby, Inc. All rights reserved.
Figures
Similar articles
-
Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.Am J Cardiol. 2016 Oct 15;118(8):1150-1157. doi: 10.1016/j.amjcard.2016.07.025. Epub 2016 Jul 29. Am J Cardiol. 2016. PMID: 27642112
-
Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention.Am J Cardiol. 2010 Oct 15;106(8):1069-74. doi: 10.1016/j.amjcard.2010.06.011. Am J Cardiol. 2010. PMID: 20920640
-
Assessment of safety of performing percutaneous coronary intervention after a recent episode of gastrointestinal bleeding.Acute Card Care. 2016 Mar;18(1):1-6. doi: 10.3109/17482941.2016.1174269. Epub 2016 Oct 27. Acute Card Care. 2016. PMID: 27786543
-
Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.Am J Cardiol. 2009 Sep 7;104(5 Suppl):22C-9C. doi: 10.1016/j.amjcard.2009.06.022. Am J Cardiol. 2009. PMID: 19695357 Review.
-
Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.Catheter Cardiovasc Interv. 2017 Aug 1;90(2):205-212. doi: 10.1002/ccd.26928. Epub 2017 Jan 23. Catheter Cardiovasc Interv. 2017. PMID: 28112470 Review.
Cited by
-
Cardiovascular and bleeding risks of inactive cancer in patients with acute myocardial infarction who received primary percutaneous coronary intervention using drug-eluting stent and dual/triple antithrombotic therapy.Cardiovasc Diagn Ther. 2022 Dec;12(6):803-814. doi: 10.21037/cdt-22-306. Cardiovasc Diagn Ther. 2022. PMID: 36605075 Free PMC article.
-
Clinical characteristics and risk factors of in-hospital gastrointestinal bleeding in patients with acute myocardial infarction.Front Cardiovasc Med. 2022 Sep 27;9:933597. doi: 10.3389/fcvm.2022.933597. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36237901 Free PMC article.
-
Percutaneous Coronary Angioplasty in Patients with Cancer: Clinical Challenges and Management Strategies.J Pers Med. 2022 Aug 25;12(9):1372. doi: 10.3390/jpm12091372. J Pers Med. 2022. PMID: 36143156 Free PMC article. Review.
-
Relationship Between Heart Failure Hospitalization Costs and Left Ventricular Ejection Fraction in an Advanced Aging Society.Circ Rep. 2021 Nov 17;4(1):48-58. doi: 10.1253/circrep.CR-21-0134. eCollection 2022 Jan 7. Circ Rep. 2021. PMID: 35083388 Free PMC article.
-
In-hospital gastrointestinal bleeding in patients with acute myocardial infarction: incidence, outcomes and risk factors analysis from China Acute Myocardial Infarction Registry.BMJ Open. 2021 Sep 7;11(9):e044117. doi: 10.1136/bmjopen-2020-044117. BMJ Open. 2021. PMID: 34493500 Free PMC article.
References
-
- Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am Heart J. 2009;157(2):369–74. - PubMed
-
- Mehta SR, Yusuf S. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J. 2000;21(24):2033–41. - PubMed
-
- Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 56(4):254–63. - PubMed
-
- Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358(21):2218–30. - PubMed
-
- Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114(8):774–82. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
